Abstract
ObjectivesSkeletal muscle mass (SMM) is most often assessed in cancer patients on abdominal computed tomography (CT) imaging at the level of the third lumbar vertebra (L3). Abdominal CT imaging is not routinely performed in head and neck cancer (HNC) patients. Recently, a novel method to assess SMM on a single transversal CT slice at the level of the third cervical vertebra (C3) was published. The objective of this study was to assess the robustness of this novel C3 measurement method in terms of interobserver agreement.Patients and methodsPatients diagnosed with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) at our center between 2007 and 2011 were evaluated. Fifty-four patients with were randomly selected for analysis. Six observers independently measured the cross-sectional muscle area (CSMA) at the level of C3 using a predefined, written protocol as instruction. Interobserver agreement was assessed using intraclass correlation coefficients (ICCs), a Bland–Altman plot and Fleiss’ kappa (κ).ResultsThe agreement in vertebra selection between all observers was excellent (Fleiss’ κ: 0.96). There was a substantial agreement between all observers in single slice selection (Fleiss’ κ: 0.61). For all CSMA measurements, ICCs were excellent (0.763–0.969; all p < 0.001). The Bland–Altman plot showed good agreement between measurements, with narrow limits of agreement.ConclusionInterobserver agreement for SMM measurement at the level of C3 was excellent. Assessment of SMM at the level of C3 is easy and robust and can performed on routinely available imaging in HNC patients.
Highlights
Skeletal muscle mass (SMM) was recently used in three studies in head and neck cancer patients [21,22,23].To be clinically useful, the C3 measurement method of SMM has to provide similar results when used by different observers
The robustness of the C3 measurement method was investigated in terms of the vertebra selection, the exact single slice selection, and the correspondence in cross-sectional muscle area (CSMA) measurements between all observers
Either C2 or C4 was selected in these patients
Summary
SMM was recently used in three studies in head and neck cancer patients [21,22,23].To be clinically useful, the C3 measurement method of SMM has to provide similar results when used by different observers. A low SMM, sometimes referred to as sarcopenia, has been associated with a higher incidence of chemotherapyrelated toxicity, postoperative complications, longer hospital stay, increased healthcare-related expenditures, and lower disease free and overall survival [5,6,7,8,9,10]. This relationship has been shown in breast, colorectal, hepato-pancreaticobiliary, renal, and lung cancer, amongst others [11,12,13,14,15]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have